World Health Organization Sounds Concern Over Acute Lack of Obesity Injections
Under one in 10 people that would benefit from weight-loss injections such as Wegovy are able to get them, caution the WHO as it issues its first advice on the medications.
Considering over a billion individuals worldwide now living with obesity, it is calling for more widespread and fairer availability to this class of drugs.
Per estimates, in excess of 2,000,000,000 will be obese by 2030 unless action is taken.
"The new guidance acknowledges that obesity is a long-term condition that can be managed with thorough and ongoing care," stated the agency's head Tedros Adhanom Ghebreyesus.
High costs, limited production capacity, and distribution challenges are major barriers to universal availability to the treatments that can assist patients in reducing substantial weight, says the body.
Skinny Jab Supply Crisis
Even in the current most optimistic scenario, the supply of such drugs would only suffice for approximately 100 million people – under 10% of the global need, as stated by the health organization.
The guideline calls on nations and manufacturers to increase access, through measures including patent sharing.
The intellectual property rights on the active ingredient – the core component of a leading brand – is set to lapse in several nations in 2026.
How Obesity Injections Function
GLP-1 drugs imitate a biological compound to reduce digestion speed, suppress the appetite and increase satiety so people consume fewer calories.
People typically see weight reduction in the initial weeks of commencing the once-weekly jabs.
Research points to patients may see weight return a year later of discontinuing the medication, as their typical food cravings return.
Being carrying excess weight raises your chance for contracting medical conditions, such as diabetes, heart disease, brain attack, and certain malignancies.
Obesity affects individuals in countries worldwide and was associated with 3.7 million fatalities worldwide in 2024, as per the health agency.